Literature DB >> 28687660

Innate IFN-γ-Producing Cells Developing in the Absence of IL-2 Receptor Common γ-Chain.

Mariana Resende1,2, Marcos S Cardoso3, Ana R Ribeiro3, Manuela Flórido3, Margarida Borges3, António Gil Castro2, Nuno L Alves3, Andrea M Cooper4, Rui Appelberg3.   

Abstract

IFN-γ is known to be predominantly produced by lymphoid cells such as certain subsets of T cells, NK cells, and other group 1 innate lymphoid cells. In this study, we used IFN-γ reporter mouse models to search for additional cells capable of secreting this cytokine. We identified a novel and rare population of nonconventional IFN-γ-producing cells of hematopoietic origin that were characterized by the expression of Thy1.2 and the lack of lymphoid, myeloid, and NK lineage markers. The expression of IFN-γ by this population was higher in the liver and lower in the spleen. Furthermore, these cells were present in mice lacking both the Rag2 and the common γ-chain (γc) genes (Rag2-/-γc-/-), indicating their innate nature and their γc cytokine independence. Rag2-/-γc-/- mice are as resistant to Mycobacterium avium as Rag2-/- mice, whereas Rag2-/- mice lacking IFN-γ are more susceptible than either Rag2-/- or Rag2-/-γc-/- These lineage-negative CD45+/Thy1.2+ cells are found within the mycobacterially induced granulomatous structure in the livers of infected Rag2-/-γc-/- animals and are adjacent to macrophages that expressed inducible NO synthase, suggesting a potential protective role for these IFN-γ-producing cells. Accordingly, Thy1.2-specific mAb administration to infected Rag2-/-γc-/- animals increased M. avium growth in the liver. Overall, our results demonstrate that a population of Thy1.2+ non-NK innate-like cells present in the liver expresses IFN-γ and can confer protection against M. avium infection in immunocompromised mice.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28687660     DOI: 10.4049/jimmunol.1601701

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

1.  Control of primary mouse cytomegalovirus infection in lung nodular inflammatory foci by cooperation of interferon-gamma expressing CD4 and CD8 T cells.

Authors:  Yvonne Lueder; Katrin Heller; Christiane Ritter; Kirsten A Keyser; Karen Wagner; Xiaokun Liu; Martin Messerle; Felix R Stahl; Stephan Halle; Reinhold Förster
Journal:  PLoS Pathog       Date:  2018-08-28       Impact factor: 6.823

2.  The role of innate lymphoid cells in selected disease states - cancer formation, metabolic disorder and inflammation.

Authors:  Agata Poniewierska-Baran; Beata Tokarz-Deptuła; Wiesław Deptuła
Journal:  Arch Med Sci       Date:  2019-11-18       Impact factor: 3.318

3.  A comprehensive transcriptomic analysis of alternate interferon signaling pathways in peripheral blood mononuclear cells in rheumatoid arthritis.

Authors:  Liang Han; Shenghao Tu; Pan Shen; Jiahui Yan; Yao Huang; Xin Ba; Tingting Li; Weiji Lin; Huihui Li; Kun Yu; Jing Guo; Ying Huang; Kai Qin; Yu Wang; Zhe Chen
Journal:  Aging (Albany NY)       Date:  2021-08-25       Impact factor: 5.682

4.  An in vitro intestinal model captures immunomodulatory properties of the microbiota in inflammation.

Authors:  Jaclyn Y Lock; Mariaelena Caboni; Philip Strandwitz; Madeleine Morrissette; Kevin DiBona; Brian A Joughin; Kim Lewis; Rebecca L Carrier
Journal:  Gut Microbes       Date:  2022 Jan-Dec

5.  Potential Novel Risk Factor for Breast Cancer: Toxocara canis Infection Increases Tumor Size Due to Modulation of the Tumor Immune Microenvironment.

Authors:  Rocío Alejandra Ruiz-Manzano; Margarita Isabel Palacios-Arreola; Rosalía Hernández-Cervantes; Víctor Hugo Del Río-Araiza; Karen Elizabeth Nava-Castro; Pedro Ostoa-Saloma; Samira Muñoz-Cruz; Jorge Morales-Montor
Journal:  Front Oncol       Date:  2020-05-29       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.